Cargando…
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
The mammalian or mechanistic target of rapamycin (mTOR) pathway plays a crucial role in regulation of cell survival, metabolism, growth and protein synthesis in response to upstream signals in both normal physiological and pathological conditions, especially in cancer. Aberrant mTOR signaling result...
Autores principales: | Tian, Tian, Li, Xiaoyi, Zhang, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387042/ https://www.ncbi.nlm.nih.gov/pubmed/30754640 http://dx.doi.org/10.3390/ijms20030755 |
Ejemplares similares
-
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
mTOR inhibitors in cancer therapy
por: Xie, Jianling, et al.
Publicado: (2016) -
Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)